Gene-environment interaction in Alzheimer's disease: A potential role for cholesterol

Neuroepidemiology

Volumn 17, Issue 5, 1998, Pages 225-232

  Chandra, Vijay ^a,b,c   Pandav, Rajesh ^a  

^a Centre for Ageing Research   (India)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c Center for Policy Research   (India)

Author keywords

Alzheimer's disease; Apolipoprotein; Cholesterol; Environment; Gene environment interaction; Genes

Indexed keywords

CHOLESTEROL;

AGED; ALZHEIMER DISEASE; CHOLESTEROL BLOOD LEVEL; ENVIRONMENTAL FACTOR; GENETIC PREDISPOSITION; GENOTYPE; HEREDITY; HUMAN; REVIEW;

EID: 0031853666     PISSN: 02515350     EISSN: None     Source Type: Journal    
DOI: 10.1159/000026175     Document Type: Review

References (62)

1. Goudsmit J, White BJ, Weitkamp LR, et al: Familial Alzheimer's disease in two kindreds of the same geographic and ethnic origin. A clinical and genetic study. J Neurol Sci 1981;49(1):79-89.
2. Foncin JF, Salmon D, Supino-Viterbo V, et al: Alzheimer's presenile dementia transmitted in an extended kindred. Rev Neurol (Paris) 1985;141(3):194-202.
3. Martin GM, Kukull WA: Do cultural differences affect Alzheimer disease? (editorial). JAMA 1996;276: 12.
4. Renvoize EB, Mindham RH, Stewart M, McDonald R, Wallace RD: Identical twins discordant for presenile dementia of the Alzheimer type. BrJ Psychiatry 1986;149:509-512.
5. Small GW, Leuchter AF, Mandelkern MA, et al: Clinical, neuroimaging, and environmental risk differences in monozygotic female twins appearing discordant for dementia of the Alzheimer type. Arch Neurol 1993;50:209-219.
6. Hunter R, Dayan AD, Wilson J: Alzheimer's disease in one monozygotic twin. J Neurol Neurosurg Psychiatry 1972;35:707-710.
7. Breitner JC, Welsh KA, Gau BA, et al: Alzheimer's disease in the National Academy of Sciences-National Research Council Registry of Aging Twin Veterans. III. Detection of cases, longitudinal results, and observations on twin concordance. Arch Neurol 1995;52:763-771.
8. Nee LE, Eldridge R, Sunderland T, et al: Dementia of the Alzheimer type: Clinical and family study of 22 twin pairs. Neurology 1987;37:359-363.
9. Gatz M, Pedersen NL, Berg S: Heritability for Alzheimer's disease: The study of dementia in Swedish twins. J Gerontol A Biol Med Sci 1997; 52A:117-125.
10. Bergem ALM: Heredity in dementia of the Alzheimer type. Clin Genet 1994;46:144-149.
11. Raihal I, Kaprio J, Koshenvuo M, et al: Alzheimer's disease in Finnish twins. Lancet 1996;347:573-578.
12. Goate A, Chartier-Harlin MC, Mullam M, et al: Segregation of a missense mutation of the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991; 349:704-706.
13. Sherrington R, Rogaev EI, Liang Y, et al: Cloning of a novel gene bearing missense mutation in early familial Alzheimer disease. Nature 1995; 375:754-760.
14. Levy-Lehad E, Wijsman EM, Memens E, et al: A familial Alzheimer's disease locus on chromosome 1. Science 1995;269:970-973.
15. Rogaev EI, Sherrington R, Rogaeva EA, et al: Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 1995;376:600-662.
16. Poirer J, Davignon J, Bouthillier D, et al: Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 1993;342:697-699.
17. Saunders AM, Strittmatter WJ, Schmechel D, et al: Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993; 43:1467-1472.
18. Van Duijn CM, de Knijff P, Cruts M, et al: Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease. Nat Genet 1994;7:74-78.
19. Okuizumi K, Onodera O, Tanaka H, et al: ApoE-e4 and early onset of Alzheimer's (letter). Nat Genet 1994;7:10-11.
20. Corder EH, Saunders AM, Strittmatter WJ, et al: Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late-onset families. Science 1993;261:921-923.
21. Consensus statement: Apolipoprotein E genotyping in Alzheimer's disease. NIA/AAWG. Lancet 1996; 347:1091-1095.
22. Myers RH, Schaefer EJ, Wilson PWF, et al: Apolipoprotein E ε4 association with dementia in a population-based study: The Framingham study. Neurology 1996;46:673-677.
23. Henderson AS, Easteal S, Jorm AF, et al: Apolipoprotein E allele e4, dementia, and cognitive decline in a population sample. Lancet 1995; 346:1387-1390.
24. Hyman BT, Gomez-Isla T, Briggs M, et al: Apolipoprotein E and cog-nitive change in an elderly population. Ann Neurol 1996;40:55-66.
25. Lannfelt L, Lilius L, Appegren H, et al: Lack of association between apolipoprotein E allele epsilon 4 and sporadic Alzheimer's disease. Neurosci Lett 1994;169:175-178.
26. Osuntokun BO, Sahota A, Ogunniyi AO, et al: Lack of an association between apolipoprotein E epsilon 4 and Alzheimer's disease in elderly Nigerians. Ann Neurol 1995;38: 463-465.
27. Pericak-Vance MA, Johnson CC, Rimmler JB, et al: Alzheimer's disease and apolipoprotein E-4 allele in an Amish population. Ann Neurol 1996;39:700-704.
28. Kamboh MI, Sanghera DK, Ferrell RE, DeKosky ST: APOE*4-associated Alzheimer's disease risk is modified by α1-antichymotrypsin polymorphism. Nat Genet 1995;10: 486-488.
29. Okuizumi K, Onodera O, Namba Y, et al: Genetic association of the very low density lipoprotein (VLDL) receptor gene with sporadic Alzheimer's disease. Nat Genet 1995;11: 207-209.
30. Zannis VI, Just PW, Breslow JL: Human apolipoprotein E isoprotein subclasses are genetically determined. Am J Hum Genet 1981; 33(1):11-24.
31. Zannis VI, Breslow JL: Human very low density lipoprotein apolipoprotein E isoprotein polymorphism is explained by genetic variation and posttranslational modification. Biochemistry 1981;20:1033-1041.
32. Utermann G, Jaeschke M, Mangel J: Familial hyperlipoproteinemia type III: Deficiency of a specific apolipoprotein (apo E-III) in the very-low-density lipoproteins. FEBS Lett 1975;56:352-355.
33. Mahley RW, Angelin B: Type III hyperlipoproteinemia: Recent insights into the genetic defects of familial dysbetalipoproteinemia. Adv Intern Med 1984;29:385-411.
34. Breslow JL, Zannis VI, SanGiacomo TR, Third JI, et al: Studies of familial type III hyperlipoproteinemia using as a genetic marker the apoE phenotype E2/2. J Lipid Res 1982; 23:1224-1235.
35. Utermann G, Kindermann I, Kaffarnik H, Steinmetz A: Apolipoprotein E phenotypes and hyperlipidemia. Hum Genet 1984;65:232-236.
36. Mahley RW, Angelin B: Type 111 hyperlipoproteinemia: Recent insights into the genetic defect of familial dysbetalipoproteinemia. Adv Intern Med 1984;29:385-411.
37. Corder EH, Saunders AM, Risch NJ, et al: Protective effect of apolipoprotein E type 2 allele for late-onset Alzheimer disease. Nat Genet 1994;7:180-184.
38. Wilson PWF, Myers RH, Larson MG, et al: Apolipoprotein E alleles, dyslipidemia, and coronary heart disease, The Framingham Offspring Study. JAMA 1994;272:1666-1671.
39. Srinath Reddy K: Diet, nutrition & chronic disease: in Shetty RS, McPherson K (eds): Lessons from Contrasting Worlds. London School of Hygiene & Tropical Medicine, Sixth Annual Public Health Forum, 1997, pp 71-75.
40. McKeigue PM, Shah B, Marmot MG: Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 1991;337: 382-386.
41. Bhatnagar D, Anand IS, Durrington PN, et al: Coronary risk factors in people from the Indian subcontinent living in West London and their siblings in India. Lancet 1995; 345:405-409.
42. Walker LC, Parker CA, Lipinski WJ, et al: Cerebral lipid deposition in aged apolipoprotein-E-deficient mice. Am J Pathol 1997;151:1371-1377.
43. Bodovitz S, Klein WL: Cholesterol modulates alpha-secretase cleavage of amyloid precursor protein. J Biol Chem 1996;271:4436-4440.
44. Racchi M, Baetta R, Salvietti N, et al: Secretory processing of amyloid precursor protein is inhibited by increase in cellular cholesterol content. Biochcm J 1997;322:893-898.
45. Streit WJ, Sparks DL: Activation of microglia in the brains of humans with heart disease and hypercholesterolemic rabbits. J Mol Med 1997; 75(2):130-138.
46. Namba Y, Tomonga H, Kawasaki H, et al: Apolipoprotein E immuno-reactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and Kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res 1991;541: 163-166.
47. Wisniewski TA, Golabek E, Matsubura E, et al: Apolipoprotein: Binding to soluble Alzheimer's β-amyloid. Biochem Biophys Res Commun 1993;192:258-365.
48. Jarvik GP, Wijsman EM, Kukull WA, Schellenberg GD, Yu C, Larson EB: Interaction of apolipoprotein E genotype, total cholesterol level, and sex in prediction of Alzheimer's disease in a case-control study. Neurology 1995;45:1092-1096.
49. Boerwinkle E, Utermann G: Simultaneous effects of the apolipoprotein E polymorphism on apolipoprotein E, apolipoprotein B, and cholesterol metabolism. Am J Hum Genet 1988;42:104.
50. Ehnholm C, Lukka M, Kussi T,et al: Apolipoprotein E polymorphism in the Finnish population: Gene frequencies and relation to lipoprotein concentrations. J Lipid Res 1986; 27:277.
51. Henderson AS: The epidemiology of Alzheimer's disease. Br Med Bull 1986;42:3-10.
52. Wadia NH: Experience with the differential diagnosis and prevalence of dementing illness in India. Curr Sci 1992;63:419-430.
53. Shaji S, Promodu K, Abraham T, Jacob RK, et al: An epidemiological study of dementia in a rural community in Kerala, India. Br J Psychiatry 1996;168:745-749.
54. Rajkumar S, Kumar S, Thara R: Prevalence of dementia in a rural setting: A report from India. Int J Geriatr Psychiatry 1997;12:702-707.
55. Barodawala SA, Ghadi PS: A progress report on the prevalence of Alzheimer's lesions in a Bombay hospital population. Curr Sci 1992; 63:449-455.
56. Shankar SK, Chandra PS, Rao TV, et al: Alzheimer's disease - histological ultrastructural and immunochemical study of an autopsy proven case. Indian J Psychiatry 1988;30: 291-298.
57. Hallmann DM, Boerwinkle E, Saha N, et al: The apolipoprotein E polymorphism: A comparison of allele frequencies and effects of nine populations. Am J Hum Genet 1991;49: 338-349.
58. Sepehrnia B, Kamboh MI, Adams-Campbell LL, Bunker CH, Nwankwo M, Majumder PP, Ferrell RE: Genetic studies of human apolipoprotein, X: The effect of the apolipoprotein E polymorphism on quantitative levels of lipoproteins in Nigerian blacks. Am J Hum Genet 1989; 45:586-691.
59. Hendrie HC, Osunlokun BO, Hall KS, et al: Prevalence of Alzheimer's disease and dementia in two communities: Nigerian Africans and African Americans. Am J Psychiatry 1995;152:1485-1492.
60. Graves AB, Larson EB, Edland SD, et al: Prevalence of dementia and its subtypes in the Japanese American population of King Country, Washington State. Am J Epidemiol 1996; 144:760-771.
61. White L, Petrovitch H, Ross GW, et al: Prevalence of dementia in older Japanese-American men in Hawaii. JAMA 1996;276:955-960.
62. Yoshiitake T, Kiyohara Y, Kato I, et al: Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: The Hisayama study. Neurology 1995;45:1161-1168.